To investigate the safety and efficacy of indocyanine green (ICG) fluorescence-guided inguinal lymphadenectomy in patients with penile cancer.
A prospective, single-blind, randomized controlled clinical trial (ChiCTR2100044584) was performed among patients with penile caner who underwent bilateral modified inguinal lymphadenectomy at four centers in China between April 1, 2021, and June 30, 2022.